FDA Inspection 869532 — Anne Greist, MD

Anne Greist, MD — FEI 3010601947

The FDA completed an inspection of Anne Greist, MD on March 12, 2014 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 12, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
751721 CFR 312.66Initial and continuing review
753021 CFR 312.62(b)Case history records- inadequate or inadequate
755221 CFR 312.66Changes in research
756021 CFR 312.60FD-1572, protocol compliance